For example, while IFX has been shown to reduce pathology and disease activity in the dextran sulphate sodium (DSS) colitis model 18, neither transcriptional inhibition of TNF‐α 22 nor genetic deficiency of TNF‐α has been shown to increase susceptibility 23. The gene discussed is TNF; the disease is colitis.